Glenmark Pharmaceuticals Ltd. | GLENMARK | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
91,85791,03198,655106,410109,439
Cost of revenue
Cost of revenue
-26,143-30,386-33,623-36,986-36,988
Gross Profit
Gross Profit
65,714
60,645
65,031
69,423
72,451
Sales, general & ad...
Sales, general and administrative
-45,347-44,491-49,173-52,442-51,607
Depreciation
Depreciation and amortization
-2,644-3,019-3,259-4,172-4,436
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
17,723
13,135
12,599
12,809
16,408
 
      
Profit before tax
Profit before tax
14,91411,19313,00610,96113,825
Net Income
Net income
11,088
8,039
9,250
7,760
9,701
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
39.29
28.49
32.78
27.50
34.38